Alexion Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ALXN
CUSIP
015351109
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q4 1 61.0 $8.83 k
2023 Q3 1 61.0 $10.4 k
2023 Q2 1 61.0 $13.6 k
2023 Q1 1 61.0 $13.0 k
2022 Q4 1 61.0 $13.0 k
2022 Q3 1 61.0 $16.0 k
2022 Q2 1 60.0 $13.0 k
2022 Q1 1 60.0 $13.0 k
2021 Q4 2 86.0 $14.0 k
2021 Q3 7 5.80 k $845 k
2021 Q2 732 211 M $38.8 B
2021 Q1 786 203 M $31.1 B
2020 Q4 875 201 M $31.7 B
2020 Q3 761 199 M $22.8 B
2020 Q2 749 200 M $22.5 B
2020 Q1 722 201 M $18.1 B
2019 Q4 725 207 M $22.4 B
2019 Q3 710 208 M $20.4 B
2019 Q2 700 214 M $28.1 B
2019 Q1 670 216 M $29.1 B
2018 Q4 659 215 M $20.9 B
2018 Q3 641 220 M $30.6 B
2018 Q2 654 214 M $26.5 B
2018 Q1 658 212 M $23.6 B
2017 Q4 647 212 M $25.3 B
2017 Q3 648 214 M $30.1 B
2017 Q2 612 214 M $26.0 B
2017 Q1 608 215 M $26.0 B
2016 Q4 607 220 M $26.9 B
2016 Q3 561 217 M $26.6 B
2016 Q2 587 218 M $25.4 B
2016 Q1 560 226 M $30.5 B
2015 Q4 590 225 M $42.9 B
2015 Q3 553 225 M $35.1 B
2015 Q2 597 220 M $39.8 B
2015 Q1 604 193 M $33.5 B
2014 Q4 612 194 M $35.9 B
2014 Q3 560 192 M $33.5 B
2014 Q2 557 194 M $30.4 B
2014 Q1 531 191 M $29.0 B